Navigation Links
Pediatric Dengue Vaccine Initiative and Hawaii Biotech Partner Against Dengue Fever

The Pediatric Dengue Vaccine Initiative (PDVI), a program of the International Vaccine Institute (IVI), and Hawaii Biotech // , announced today their partnership to help develop and make a Dengue vaccine widely available for the global prevention of Dengue fever, the second most widespread tropical disease after malaria.

Dengue fever is a mosquito-borne disease to which over 2 billion people are exposed and which leads to infection in up to 100 million people every year, primarily children. Dengue infection results in about 20,000 deaths from dengue hemorrhagic fever and dengue shock syndrome, the most severe forms of the disease, according to estimates from the World Health Organization (WHO)*.

"Our primary objective is to ensure rapid introduction of Dengue vaccines into immunization programs in all affected areas as soon as a vaccine becomes available. Working with Hawaii Biotech puts us in collaboration with one of the leading companies concerned with this important disease” said Harold Margolis, Director of the PDVI. "

Dengue is a mosquito transmitted disease and occurs mostly in urban areas of Latin American and Asia with an unknown level in Africa. The disease causes substantial illness and significant economic costs for hospitalizations and treatment. Efforts to control the mosquitoes are expensive, of varying success, and difficult to sustain.

The IVI, based in Seoul, Korea, is the world’s only International Organization solely dedicated to vaccine research and development.

“The IVI has grown rapidly in its short life and we are enthusiastic about this close association with Hawaii Biotech. We believe this partnership will greatly accelerate our work to reduce the burden of dengue in developing countries” said Dr. John Clemens, Director General of IVI.

Hawaii Biotech has a long involvement in development of dengue vaccines and is the only company pursuing a novel approach that relies on p roduction of virus components through genetic technologies. Vaccines made with this modern technology are known for being very safe and effective.

“Hawaii Biotech’s state-of-the-art vaccine protein manufacturing process is ideal to address emerging and re-emerging infectious diseases at their origin in developing countries. We’re delighted to enter into this partnership with PDVI, and appreciate their recognition of our R&D program’s excellence and promise”, commented Leonard Firestone, MD, President and Chief Executive Officer.

Source-Newswis
SRM
'"/>




Related medicine news :

1. Support Services found to Dramatically Impact Pediatric Health Care
2. Pediatricians differ in their opinion of child abuse
3. New Treatment Discovered For Pediatric Cholera
4. Pediatricians Need To Talk To Parents Of Overweight Kids
5. A New Diagnostic Approach To Pediatric Interstitial Lung Disease
6. FDA Accords Priority Review For Pediatric Crohns Disease Drug
7. WHO Updates Outdated Pediatric Growth Charts
8. Pediatricians Resignations Cause Concern at Sale
9. Mental Health Providers Can Be Successfully Located With Pediatricians
10. World’s First Pediatric Laparoscopic Liver Surger
11. Pediatric Dental Care Found Wanting
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/20/2017)... ... 20, 2017 , ... Sensogram Technologies Inc., the world leader ... this week at HIMSS 2017 Conference & Exhibition. The event brings more than ... be featured in the conference’s Connected Health Experience section, an area specifically designed ...
(Date:2/20/2017)... ... ... Johns Hopkins All Children's Hospital celebrated a major milestone with the topping ... the halfway point of construction and lifting of the final beam on the top ... center for innovation aimed at finding new discoveries and treatments for childhood diseases. The ...
(Date:2/19/2017)... , ... February 19, 2017 , ... The Citadel’s new ... nursing students, is being led by Amelia Joseph, Ph.D. Joseph was engaged by the ... of the nursing department in early 2016. After a nation-wide search, she was selected ...
(Date:2/19/2017)... , ... February 19, 2017 , ... ... for connected home healthcare, will join forces with Healthwise ® at ... Healthwise, the industry leader in evidence-based health education, technology and services, will ...
(Date:2/18/2017)... Beverly Hills, California (PRWEB) , ... February 17, ... ... 273-3007, info@drvallecillos.com , drvallecillos.com , Beverly Hills plastic surgeon ... reduce subcutaneous fat cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... -- The Global PSA Oxygen Concentrators Industry 2017 ... analysis of the PSA Oxygen Concentrators market. From a basic ... and industry chain overview are all covered in the report. ... and investment return analysis of the PSA Oxygen Concentrators industry. ... Browse ...
(Date:2/20/2017)... 20, 2017  National Decision Support Company (NDSC) ... company,s CareSelect Imaging platform within the full range ... the technical foundation for MEDITECH sites, through a ... Clinical Decision Support Mechanism through the MEDITECH EHR. ... and support the integration of NDSC,s mechanism, which ...
(Date:2/20/2017)... Research and Markets has announced the addition of the "South ... 2017 - 2022" report to their offering. ... South Korea Medical Tourism Market ... end of 2022 growing at a CAGR of around 15% from ... to factors such as technologically advanced treatments and medical procedures, pioneer ...
Breaking Medicine Technology: